Back to Search
Start Over
A real-world study of panobinostat, weekly bortezomib and dexamethasone in a very heavily pretreated population of multiple-myeloma patients.
- Source :
-
British journal of haematology [Br J Haematol] 2020 Dec; Vol. 191 (5), pp. 927-930. Date of Electronic Publication: 2020 Sep 10. - Publication Year :
- 2020
- Subjects :
- Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols adverse effects
Bortezomib administration & dosage
Bortezomib adverse effects
Dexamethasone administration & dosage
Dexamethasone adverse effects
Female
Humans
Male
Middle Aged
Multiple Myeloma pathology
Panobinostat administration & dosage
Panobinostat adverse effects
Retrospective Studies
Antineoplastic Combined Chemotherapy Protocols administration & dosage
Multiple Myeloma drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1365-2141
- Volume :
- 191
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- British journal of haematology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 33460042
- Full Text :
- https://doi.org/10.1111/bjh.17076